Jbt Marel’s Agv Recovery Timelines and Capital Allocation Priorities Clash in Earnings Calls

Date of Call: Aug 4, 2026

Financials Results

• Revenue: $981 million, an increase of 5% year-over-year (3% organic, 2% from foreign exchange)

Guidance:

• Q3 2026 revenue growth guided at 2% to 4% organic, partially offset by 1% FX impact.
• Q3 2026 adjusted EBITDA margin guided at 17% to 17.5%.
• Expect a steeper ramp in Q4 2026 results compared to Q3.
• Full year 2026 guidance for revenue and adjusted EBITDA maintained, reflecting consolidated revenue growth of 6% and adjusted EBITDA margin expansion of 145 basis points at the midpoint.
• Adjusted EPS guidance refined to reflect updated assumptions for depreciation, amortization, and effective tax rate.

Business Commentary:

Strong Orders Growth and Segment Performance:

• JBT-MARL reported a 10% year-over-year increase in orders, marking the third consecutive quarter with orders exceeding $1 billion.
• This growth was driven by double-digit year-over-year growth in the prepared food and beverage solution segment, particularly in value-added prepared foods technology, and synergistic cross-selling initiatives.

Revenue and Margin Dynamics:

• Second quarter consolidated revenue was $981 million, a 5% year-over-year increase, comprising 3% organic growth and 2% from foreign exchange.
• The prepared food and beverage segment's revenue was flat year-over-year due to logistics constraints and production inefficiencies, while protein segment revenue grew 11% due to volume leverage and synergy actions.

Cost Synergy and Restructuring Initiatives:

• JBT-MARL is advancing its footprint optimization strategy, aiming for a 15% reduction in its global footprint, which includes the consolidation of facilities.
• Restructuring efforts in the warehouse automation business are expected to generate approximately $9 million in total annual savings, with $3 million anticipated in the second half of 2026.

Backlog Visibility and Future Outlook:

• The company has record backlog visibility, covering over 90% of back half equipment revenue, providing confidence in achieving its second half 2026 forecast and long-term financial targets.
• Continued investment in poultry and other protein sources, along with global efforts to become more self-sufficient in protein production, supports a positive outlook for future growth.

Sentiment Analysis:

Overall Tone: Positive

• Management expressed being 'very pleased' with robust demand and record backlog, 'thrilled' with profitable growth in the protein segment, and confidence in achieving 2028 margin targets. They noted 'strong orders,' 'continued profitable growth,' and that 'our backlogged visibility, integration efforts, and continuous improvement initiatives gives us confidence.'

Q&A:

• Question from Meg Dobre (Baird): Clarification on the guide and thoughts on prepared food and beverage margin cadence relative to Q2, and any catch-up of revenue pushed from Q2 into Q3/Q4.
  Response: Approximately $20 million in Q2 revenue was delayed due to logistics and production inefficiencies, redistributed across the back half, impacting EBITDA by ~$5-6 million. Expect PFB segment margins to improve year-over-year by 25-50 bps in Q3 and see another ~100 bps improvement from Q3 to Q4.

• Question from Meg Dobre (Baird): Follow-up on protein margins, contribution from IEPA refunds, and back half margin outlook.
  Response: Protein segment margins were ~24% in Q2, with a ~200 bps benefit from tariff refunds; underlying margins are in the low-to-mid 20% range. Expect relatively flat margins in the back half due to mix shift towards equipment.

• Question from Justin Ages (CJS Securities): Elaboration on strength in protein solutions outside of poultry.
  Response: Poultry is the largest and strongest segment. Pork, fish, and beef show more modest strength; beef is the weakest (<5% of protein portfolio). The overall protein market remains positive.

• Question from Justin Ages (CJS Securities): Indication if improvement in the AGV business beyond Q2 is being sustained.
  Response: Yes, AGV saw its strongest quarter in six quarters on volume in Q2, with demand strength expected to continue into the back half, supporting a nice ramp-up.

• Question from Ross Sparenbleck (William Blair): Status of backlog from 2025 pricing actions and impact of inflationary costs and additional pricing actions in 2026.
  Response: Pricing actions for known costs are embedded in backlog and guidance. Ongoing inflation in logistics (e.g., $100M annual spend) has caused some cost leakage not fully recovered yet; this is reflected in updated guidance.

• Question from Ross Sparenbleck (William Blair): Why guidance wasn't increased given strong orders and backlog, considering the caution around logistics.
  Response: Given Q2 pressure from logistics and facility relocations, it was prudent to maintain full-year revenue guidance flat, with expectations for make-up in Q3 and Q4.

• Question from Walt Liptack (Seaport Research): Whether general industrial trends (e.g., improving ISMs) are beneficial to the outlook, given strong new orders.
  Response: A strong economy provides confidence, but the unique strong protein consumption trend is particularly beneficial, supporting ~70% of overall revenues. Some pockets of weakness exist in CPG.

• Question from Walt Liptack (Seaport Research): Timeline for completing factory consolidations.
  Response: Consolidations are phased: some in Q2/Q3 2026, with larger facilities moving in 2027 (mid-2027 and end-2027). Future moves will be smoother as receiving plants already produce the products.

• Question from Walt Liptack (Seaport Research): Capital allocation priorities between share buybacks and M&A.
  Response: Currently focused on integration; M&A is for the future. Share buybacks are being done opportunistically relative to price, with balance sheet and management capacity also considered.

• Question from Ian Zaffino (Oppenheimer): Customer feedback on end-customer demand and consumer state.
  Response: Demand is mixed: CPG customers see trade-offs (e.g., branded vs. generic), with some category-specific shifts (e.g., snacks). Protein customers report strong demand, with focus on value-added and prepared foods.

• Question from Ian Zaffino (Oppenheimer): Update on USDA inspection line speed for chickens and implications.
  Response: Expect a decision from USDA late summer or early fall. Allowing line speeds to increase from 140 to 175 birds per minute would be a multi-year tailwind, improving productivity and strengthening JBT's value proposition.

• Question from Meg Dobre (Baird): Thoughts on order consistency and visibility into 2027, including any shift from protein solutions to prepared food and beverage.
  Response: Poultry demand remains very strong globally. While primary/secondary investment has been high, prepared foods orders grew 15% YOY in Q2, showing strength. Backlog extends into 2027, with pipeline remaining strong for both segments.

Contradiction Point 1

Warehouse Automation (AGV) Business Recovery and Outlook

Contradiction on the business's current performance and the sustainability of its recovery.

Justin Ages (CJS Securities) - Justin Ages (CJS Securities)

2026Q2: Yes, improvement is sustained. AGV had its strongest quarter in six on volume in Q2, driven by recovering demand. Combined with restructuring, AGV is expected to see a nice ramp in H2. - Brian Deck(CEO)

Can you elaborate on the strength in the protein solutions segment outside of poultry and whether the improvement in the warehouse automation (AGV) business beyond Q2 is being sustained? - Justin Ages (CJS Securities, Inc.)

2026Q1: The business was more impacted by tariff changes on its customers than other segments, leading to lower demand. A few discrete projects... affected performance. Actions are being taken to address the lower volume and improve margins, with expected impacts starting in Q2 and continuing into Q3 and Q4. - Matthew Meister(CFO) & Brian Deck(CEO)

Contradiction Point 2

Prepared Foods Segment Organic Growth Outlook

Contradiction on the level of organic growth expected for the prepared foods segment.

What was the follow-up question from Meg Dobre of Baird? - Meg Dobre (Baird) – Follow-up

2026Q2: For the full year, organic growth is expected to be in the mid-single digits, likely around 3-4%... but is expected to improve with built-up backlog. - Brian Deck(CEO) & Matthew Meister(CFO)

Given the consistent quarterly orders ($1.3B-$1.7B), how do you view the sustainability of this demand cycle and potential shifts in order mix between protein solutions and prepared foods by 2027? - Mircea Dobre (Robert W. Baird & Co. Incorporated)

2026Q1: [The company expects year-over-year margin expansion in the Prepared Food and Beverage segment for the full year.] - Brian Deck(CEO) & Matthew Meister(CFO)

Contradiction Point 3

Nature and Drivers of the Current Poultry Demand Cycle

Contradiction on whether the strong demand cycle is driven by broad-based secular trends.

Walt Liptack (Seaport Research) - Walt Liptack (Seaport Research)

2026Q2: The strong protein consumption trend is unique to food production and is a major driver. ... The protein focus (~70% of revenue) is the key tailwind. - Brian Deck(CEO)

How does your cycle compare to general industrial trends, and are improving U.S. industrial indicators (like ISM) beneficial to your outlook? - Mircea Dobre (Robert W. Baird & Co. Incorporated)

2026Q1: Strong demand is driven by secular tailwinds like the protein shift in diets and the ongoing recovery of the industry supply-demand balance. - Brian Deck(CEO) & Arni Sigurdsson(President)

Contradiction Point 4

AGV Business Recovery Timeline

The expected timeline for the AGV business to recover and see improvement is presented differently.

Justin Ages (CJS Securities) - Justin Ages (CJS Securities)

2026Q2: AGV had its strongest quarter in six on volume in Q2, driven by recovering demand. Combined with restructuring, AGV is expected to see a nice ramp in H2. - Brian Deck(CEO)

Can you elaborate on the strength in the protein solutions segment outside of poultry and whether the improvement in the warehouse automation (AGV) business beyond Q2 is being sustained? - Ross Sparenblek (William Blair & Company L.L.C.)

2025Q4: Investment in AGV is expected to recover in 2026. - Brian Deck(CEO)

Contradiction Point 5

Capital Allocation Priorities

The stated priority for using liquidity and cash flow is presented with different focuses.

Walt Liptack (Seaport Research) - Walt Liptack (Seaport Research)

2026Q2: M&A is focused on integration in the near term. The $200M share buyback program is opportunistic, balancing share repurchases and debt paydown based on market price. - Brian Deck(CEO), Matt Meister(CFO), Arne Sigurdsson(CFO)

Are you on a different cycle than general industrial trends, are improving U.S. industrial indicators (like ISM) beneficial to your outlook, when will the factory consolidations be completed, and what are your capital allocation priorities between buyback and M&A? - Justin Ages (CJS Securities, Inc.)

2025Q4: The priority remains completing the integration and reaching the 2-2.5x leverage target before significant M&A... For 2026 specifically, the company expects to use liquidity from its revolver and generate cash flow to retire the convertible notes, aiming for 2-2.5x leverage by year-end. - Brian Deck(CEO), Arni Sigurdsson(CFO), Matthew Meister(CFO)